BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 3 filers reported holding BEAM THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $98,460 | -73.0% | 4,094 | -64.1% | 0.00% | -75.0% |
| Q2 2023 | $364,609 | +210656.6% | 11,419 | +101.7% | 0.01% | +100.0% |
| Q1 2023 | $173 | +183.6% | 5,660 | +260.5% | 0.01% | +100.0% |
| Q4 2022 | $61 | -100.0% | 1,570 | -95.4% | 0.00% | -88.9% |
| Q3 2022 | $1,642,000 | +75.4% | 34,463 | +42.5% | 0.03% | +28.6% |
| Q2 2022 | $936,000 | -28.2% | 24,182 | +6.3% | 0.02% | +75.0% |
| Q1 2022 | $1,303,000 | +506.0% | 22,749 | +745.7% | 0.01% | +200.0% |
| Q4 2021 | $215,000 | -42.8% | 2,690 | -37.7% | 0.00% | -60.0% |
| Q3 2021 | $376,000 | +32.9% | 4,316 | +96.6% | 0.01% | +42.9% |
| Q2 2021 | $283,000 | -83.6% | 2,195 | -89.8% | 0.01% | -75.9% |
| Q1 2021 | $1,726,000 | +505.6% | 21,565 | +517.9% | 0.03% | +222.2% |
| Q4 2020 | $285,000 | -35.1% | 3,490 | -80.4% | 0.01% | +80.0% |
| Q3 2020 | $439,000 | +501.4% | 17,839 | +582.4% | 0.01% | +66.7% |
| Q2 2020 | $73,000 | – | 2,614 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HSG Holding Ltd | 1,127,934 | $31,582,000 | 5.60% |
| Omega Fund Management, LLC | 302,821 | $8,479,000 | 2.32% |
| Redmile Group, LLC | 3,356,958 | $93,995,000 | 1.74% |
| BRANDYWINE MANAGERS, LLC | 10,875 | $305,000 | 1.25% |
| DC Investments Management, LLC | 88,100 | $2,467,000 | 0.91% |
| Alphabet Inc. | 663,691 | $18,583,000 | 0.86% |
| Cormorant Asset Management, LP | 796,429 | $22,036,000 | 0.84% |
| HHLR ADVISORS, LTD. | 2,966,403 | $83,059,000 | 0.76% |
| Temasek Holdings (Private) Ltd | 3,354,641 | $93,930,000 | 0.56% |
| Granahan Investment Management | 96,598 | $2,705,000 | 0.10% |